Aesthetic Historical Balance Sheet

AIH Stock

USD 0.37 0.02 5.13%

Trend analysis of Aesthetic Medical Intl balance sheet accounts such as Total Assets of 782.8 M, Short and Long Term Debt Total of 354.5 M or Other Current Liab of 82 M provides information on Aesthetic Medical's total assets, liabilities, and equity, which is the actual value of Aesthetic Medical Intl to its prevalent stockholders. By breaking down trends over time using Aesthetic Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Aesthetic Medical Intl latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aesthetic Medical Intl is a good buy for the upcoming year.

Aesthetic Medical Inventory

27.92 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aesthetic Medical Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

About Aesthetic Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Aesthetic Medical Intl at a specified time, usually calculated after every quarter, six months, or one year. Aesthetic Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Aesthetic Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Aesthetic currently owns. An asset can also be divided into two categories, current and non-current.

Aesthetic Medical Balance Sheet Chart

Aesthetic Medical Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Aesthetic Medical Intl uses and utilizes its capital. It also shows what exactly a company owns and owes.

As of now, Aesthetic Medical's Short Term Investments are increasing as compared to previous years. The Aesthetic Medical's current Liabilities And Stockholders Equity is estimated to increase to about 701.3 M, while Short and Long Term Debt Total is projected to decrease to under 354.5 M.

Total Assets Other Current Liab Total Current Liabilities Other Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Aesthetic Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aesthetic Medical Intl books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Aesthetic Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Aesthetic Medical Intl are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Aesthetic Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Aesthetic Medical Intl current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aesthetic Medical Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

	2021	2022	2023	2024 (projected)
Total Current Liabilities	541.7M	543.8M	625.4M	331.3M
Other Current Liabilities	89.4M	62.7M	72.1M	82.0M

Total Current Liabilities Other Current Liab

Aesthetic Medical balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.65	0.18	0.73	0.8	0.56	-0.24	0.24	-0.19	0.38	-0.61	-0.27	0.47	0.91	-0.65	0.7	0.63	0.39	-0.01	0.02	0.25	0.44	0.01	0.75	0.41	0.9
Other Current Liab	0.65		0.52	0.19	0.28	-0.08	-0.64	0.52	-0.59	0.46	-0.55	-0.68	0.4	0.6	-0.7	0.68	0.91	-0.18	0.2	0.43	0.6	0.66	-0.38	0.1	0.58	0.75
Total Current Liabilities	0.18	0.52		-0.32	-0.14	-0.23	-0.93	0.94	-0.84	0.86	-0.74	-0.85	-0.35	0.12	-0.84	0.77	0.78	-0.33	-0.27	0.8	-0.18	0.86	-0.86	-0.31	0.93	0.58
Total Stockholder Equity	0.73	0.19	-0.32		0.76	0.55	0.31	-0.27	0.4	-0.02	-0.24	0.32	0.76	0.73	-0.09	0.14	0.07	0.62	0.37	-0.59	0.35	-0.14	0.63	0.87	-0.05	0.44
Other Liab	0.8	0.28	-0.14	0.76		0.74	0.18	-0.01	0.12	0.07	-0.17	0.07	0.55	0.93	-0.34	0.29	0.29	0.4	-0.12	-0.11	0.13	-0.03	0.34	0.86	0.05	0.63
Net Tangible Assets	0.56	-0.08	-0.23	0.55	0.74		0.38	-0.2	0.42	-0.07	0.01	0.39	0.05	0.57	-0.2	0.26	-0.04	0.8	-0.54	-0.08	-0.22	-0.18	0.34	0.83	-0.1	0.42
Retained Earnings	-0.24	-0.64	-0.93	0.31	0.18	0.38		-0.88	0.93	-0.8	0.79	0.95	0.25	-0.12	0.82	-0.78	-0.83	0.45	0.1	-0.71	0.04	-0.94	0.89	0.36	-0.89	-0.59
Accounts Payable	0.24	0.52	0.94	-0.27	-0.01	-0.2	-0.88		-0.89	0.93	-0.69	-0.89	-0.28	0.2	-0.79	0.73	0.81	-0.42	-0.23	0.79	-0.1	0.87	-0.84	-0.19	0.95	0.59
Cash	-0.19	-0.59	-0.84	0.4	0.12	0.42	0.93	-0.89		-0.76	0.65	0.99	0.26	-0.12	0.72	-0.65	-0.8	0.66	0.13	-0.74	0.06	-0.89	0.91	0.39	-0.81	-0.5
Other Assets	0.38	0.46	0.86	-0.02	0.07	-0.07	-0.8	0.93	-0.76		-0.82	-0.78	-0.2	0.26	-0.78	0.77	0.75	-0.19	-0.14	0.56	-0.1	0.88	-0.71	0.04	0.97	0.65
Long Term Debt	-0.61	-0.55	-0.74	-0.24	-0.17	0.01	0.79	-0.69	0.65	-0.82		0.69	0.0	-0.4	0.84	-0.87	-0.73	-0.02	-0.02	-0.29	0.08	-0.87	0.55	-0.14	-0.86	-0.78
Cash And Short Term Investments	-0.27	-0.68	-0.85	0.32	0.07	0.39	0.95	-0.89	0.99	-0.78	0.69		0.17	-0.19	0.75	-0.7	-0.86	0.61	0.07	-0.72	-0.04	-0.91	0.88	0.32	-0.84	-0.57
Net Receivables	0.47	0.4	-0.35	0.76	0.55	0.05	0.25	-0.28	0.26	-0.2	0.0	0.17		0.61	0.1	-0.13	0.15	0.12	0.73	-0.52	0.77	-0.24	0.62	0.49	-0.18	0.22
Good Will	0.91	0.6	0.12	0.73	0.93	0.57	-0.12	0.2	-0.12	0.26	-0.4	-0.19	0.61		-0.57	0.53	0.58	0.3	-0.01	0.06	0.31	0.23	0.15	0.75	0.3	0.82
Common Stock Shares Outstanding	-0.65	-0.7	-0.84	-0.09	-0.34	-0.2	0.82	-0.79	0.72	-0.78	0.84	0.75	0.1	-0.57		-0.97	-0.89	0.0	0.35	-0.67	0.1	-0.85	0.66	-0.16	-0.87	-0.92
Short Term Investments	0.7	0.68	0.77	0.14	0.29	0.26	-0.78	0.73	-0.65	0.77	-0.87	-0.7	-0.13	0.53	-0.97		0.85	0.13	-0.33	0.58	-0.08	0.87	-0.64	0.23	0.85	0.91
Inventory	0.63	0.91	0.78	0.07	0.29	-0.04	-0.83	0.81	-0.8	0.75	-0.73	-0.86	0.15	0.58	-0.89	0.85		-0.25	-0.04	0.65	0.3	0.85	-0.62	0.07	0.84	0.85
Other Current Assets	0.39	-0.18	-0.33	0.62	0.4	0.8	0.45	-0.42	0.66	-0.19	-0.02	0.61	0.12	0.3	0.0	0.13	-0.25		-0.2	-0.41	-0.09	-0.28	0.52	0.72	-0.19	0.21
Other Stockholder Equity	-0.01	0.2	-0.27	0.37	-0.12	-0.54	0.1	-0.23	0.13	-0.14	-0.02	0.07	0.73	-0.01	0.35	-0.33	-0.04	-0.2		-0.6	0.72	-0.14	0.4	-0.04	-0.14	-0.2
Total Liab	0.02	0.43	0.8	-0.59	-0.11	-0.08	-0.71	0.79	-0.74	0.56	-0.29	-0.72	-0.52	0.06	-0.67	0.58	0.65	-0.41	-0.6		-0.23	0.62	-0.84	-0.38	0.64	0.4
Long Term Investments	0.25	0.6	-0.18	0.35	0.13	-0.22	0.04	-0.1	0.06	-0.1	0.08	-0.04	0.77	0.31	0.1	-0.08	0.3	-0.09	0.72	-0.23		-0.05	0.32	0.16	-0.06	0.1
Short Long Term Debt	0.44	0.66	0.86	-0.14	-0.03	-0.18	-0.94	0.87	-0.89	0.88	-0.87	-0.91	-0.24	0.23	-0.85	0.87	0.85	-0.28	-0.14	0.62	-0.05		-0.85	-0.12	0.92	0.71
Total Current Assets	0.01	-0.38	-0.86	0.63	0.34	0.34	0.89	-0.84	0.91	-0.71	0.55	0.88	0.62	0.15	0.66	-0.64	-0.62	0.52	0.4	-0.84	0.32	-0.85		0.51	-0.75	-0.36
Intangible Assets	0.75	0.1	-0.31	0.87	0.86	0.83	0.36	-0.19	0.39	0.04	-0.14	0.32	0.49	0.75	-0.16	0.23	0.07	0.72	-0.04	-0.38	0.16	-0.12	0.51		-0.03	0.5
Common Stock	0.41	0.58	0.93	-0.05	0.05	-0.1	-0.89	0.95	-0.81	0.97	-0.86	-0.84	-0.18	0.3	-0.87	0.85	0.84	-0.19	-0.14	0.64	-0.06	0.92	-0.75	-0.03		0.72
Property Plant Equipment	0.9	0.75	0.58	0.44	0.63	0.42	-0.59	0.59	-0.5	0.65	-0.78	-0.57	0.22	0.82	-0.92	0.91	0.85	0.21	-0.2	0.4	0.1	0.71	-0.36	0.5	0.72

Click cells to compare fundamentals

Aesthetic Medical Account Relationship Matchups

Aesthetic Medical balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.0B	1.0B	576.9M	546.4M	628.3M	782.8M
Short Long Term Debt Total	342.3M	460.8M	405.9M	393.1M	452.1M	354.5M
Other Current Liab	79.0M	87.7M	89.4M	62.7M	72.1M	82.0M
Total Current Liabilities	265.3M	301.7M	541.7M	543.8M	625.4M	331.3M
Total Stockholder Equity	547.5M	390.9M	(156.7M)	(113.7M)	(102.3M)	(97.2M)
Other Liab	2.3M	12.7M	21.6M	285K	327.8K	311.4K
Net Tangible Assets	372.1M	182.5M	(193.9M)	(150.9M)	(135.8M)	(129.0M)
Retained Earnings	(242.2M)	(477.9M)	(1.1B)	(1.1B)	(1.0B)	(975.4M)
Accounts Payable	17.0M	33.7M	31.3M	46.8M	53.8M	27.1M
Cash	154.5M	44.4M	39.3M	12.2M	10.9M	10.4M
Non Current Assets Total	782.4M	831.9M	463.2M	468.8M	539.1M	517.0M
Non Currrent Assets Other	57.7M	51.9M	16.6M	48.4M	55.6M	40.9M
Other Assets	77.4M	83.2M	62.3M	109.5M	126.0M	77.3M
Long Term Debt	12.9M	110.1M	115.7M	29.1M	26.2M	24.9M
Cash And Short Term Investments	154.5M	44.4M	39.3M	12.2M	10.9M	10.4M
Net Receivables	84.1M	119.7M	43.9M	10.5M	9.5M	9.0M
Good Will	115.2M	161.5M	54.4M	33.0M	37.9M	36.1M
Common Stock Shares Outstanding	23.6M	21.7M	22.0M	27.3M	24.6M	30.4M
Short Term Investments	1.02	1.24	62.4M	42.2M	48.5M	50.9M
Liabilities And Stockholders Equity	1.0B	1.0B	576.9M	546.4M	628.3M	701.3M
Non Current Liabilities Total	191.2M	310.7M	221.7M	128.4M	147.7M	221.8M
Capital Lease Obligations	201.9M	214.9M	134.0M	126.7M	145.7M	106.5M
Inventory	26.1M	33.3M	30.6M	27.9M	32.0M	27.9M
Other Stockholder Equity	260.5M	901.2M	(41K)	(2.0M)	(1.8M)	(1.7M)
Total Liab	456.5M	612.4M	763.4M	672.3M	773.1M	606.1M
Long Term Investments	10.3M	8.3M	4.9M	1.2M	1.0M	991.8K
Property Plant And Equipment Gross	534.7M	531.9M	735.7M	698.3M	803.1M	470.4M
Short Long Term Debt	127.5M	135.8M	156.2M	237.3M	272.9M	286.6M
Total Current Assets	264.7M	206.2M	113.7M	77.6M	69.8M	66.3M
Accumulated Other Comprehensive Income	789.3M	870.4M	909.4M	1.0B	1.2B	694.8M
Short Term Debt	163.7M	171.7M	184.5M	264.7M	304.4M	319.6M
Intangible Assets	60.2M	46.9M	(17.2M)	4.3M	3.8M	3.7M
Property Plant Equipment	519.3M	531.9M	358.7M	320.8M	368.9M	370.1M
Property Plant And Equipment Net	519.3M	531.9M	358.7M	320.8M	368.9M	399.0M
Current Deferred Revenue	5.5M	8.6M	236.5M	169.7M	195.2M	204.9M
Net Debt	187.8M	416.4M	366.6M	380.9M	438.1M	329.7M
Net Invested Capital	687.9M	636.8M	115.2M	152.8M	137.5M	130.6M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aesthetic Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aesthetic Medical's short interest history, or implied volatility extrapolated from Aesthetic Medical options trading.

Pair Trading with Aesthetic Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aesthetic Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aesthetic Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aesthetic Stock

0.65

FIGS

Figs Inc Financial Report 2nd of May 2024

Pair Corr

Moving against Aesthetic Stock

0.63	WGS	GeneDx Holdings Corp Earnings Call This Week	Pair Corr
0.57	HQY	HealthEquity Financial Report 3rd of June 2024	Pair Corr
0.52	FORA	Forian Inc Financial Report 10th of May 2024	Pair Corr
0.49	RMD	ResMed Inc Earnings Call This Week	Pair Corr
0.45	VMD	Viemed Healthcare	Pair Corr

The ability to find closely correlated positions to Aesthetic Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aesthetic Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aesthetic Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aesthetic Medical Intl to buy it.

The correlation of Aesthetic Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aesthetic Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aesthetic Medical Intl moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aesthetic Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Aesthetic Medical Intl offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aesthetic Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aesthetic Medical Intl Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aesthetic Medical Intl Stock:

How To Invest In Aesthetic

Details

Is Aesthetic Stock a good investment?

Details

What is Aesthetic Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Aesthetic Stock analysis

When running Aesthetic Medical's price analysis, check to measure Aesthetic Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aesthetic Medical is operating at the current time. Most of Aesthetic Medical's value examination focuses on studying past and present price action to predict the probability of Aesthetic Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aesthetic Medical's price. Additionally, you may evaluate how the addition of Aesthetic Medical to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Global Correlations Find global opportunities by holding instruments from different markets

Is Aesthetic Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aesthetic Medical. If investors know Aesthetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aesthetic Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

12.19

Earnings Share

(0.40)

Revenue Per Share

17.449

Quarterly Revenue Growth

(0.04)

Return On Assets

(0.04)

The market value of Aesthetic Medical Intl is measured differently than its book value, which is the value of Aesthetic that is recorded on the company's balance sheet. Investors also form their own opinion of Aesthetic Medical's value that differs from its market value or its book value, called intrinsic value, which is Aesthetic Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aesthetic Medical's market value can be influenced by many factors that don't directly affect Aesthetic Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aesthetic Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aesthetic Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aesthetic Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aesthetic Historical Balance Sheet

Aesthetic Medical Inventory

27.92 Million

About Aesthetic Balance Sheet Analysis

Aesthetic Medical Balance Sheet Chart

Total Assets

Total Current Liabilities

Aesthetic Medical balance sheet Correlations

Aesthetic Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aesthetic Medical balance sheet Accounts

Pair Trading with Aesthetic Medical

Moving together with Aesthetic Stock

Moving against Aesthetic Stock

Complementary Tools for Aesthetic Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Accumulated Amortization	Total Assets
Short Long Term Debt Total	Other Current Liab
Total Current Liabilities	Total Stockholder Equity
Other Liab	Net Tangible Assets
Total Permanent Equity	Warrants
Noncontrolling Interest In Consolidated Entity	Retained Earnings
Accounts Payable	Cash
Non Current Assets Total	Non Currrent Assets Other
Other Assets	Long Term Debt
Cash And Short Term Investments	Net Receivables
Good Will	Common Stock Total Equity
Retained Earnings Total Equity	Common Stock Shares Outstanding
Short Term Investments	Long Term Debt Total
Liabilities And Stockholders Equity	Non Current Liabilities Total
Capital Surpluse	Capital Lease Obligations
Negative Goodwill	Inventory
Other Current Assets	Other Stockholder Equity
Total Liab	Additional Paid In Capital
Deferred Long Term Liab	Preferred Stock Redeemable
Long Term Investments	Property Plant And Equipment Gross
Short Long Term Debt	Preferred Stock Total Equity
Total Current Assets	Accumulated Other Comprehensive Income
Treasury Stock	Non Current Liabilities Other
Accumulated Depreciation	Deferred Long Term Asset Charges
Short Term Debt	Intangible Assets
Common Stock	Temporary Equity Redeemable Noncontrolling Interests
Property Plant Equipment	Property Plant And Equipment Net
Current Deferred Revenue	Net Debt
Net Invested Capital	Net Working Capital
Capital Stock

Cash And Short Term Investments	+ 0.99	Cash
Common Stock	+ 0.97	Other Assets
Cash And Short Term Investments	+ 0.95	Retained Earnings
Common Stock	+ 0.95	Accounts Payable
Accounts Payable	+ 0.94	Total Current Liabilities
Common Stock	+ 0.93	Total Current Liabilities

Short Term Investments	- 0.97	Common Stock Shares Outstanding
Short Long Term Debt	- 0.94	Retained Earnings
Retained Earnings	- 0.93	Total Current Liabilities
Property Plant Equipment	- 0.92	Common Stock Shares Outstanding
Short Long Term Debt	- 0.91	Cash And Short Term Investments
Inventory	- 0.89	Common Stock Shares Outstanding